Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
01 1ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański PL
02 1Chemische Fabrik Berg GmbH Bitterfeld-Wolfen DE
03 1CTX LIFESCIENCES PVT. LIMITED Surat IN
04 1SIEGFRIED EVIONNAZ SA Evionnaz CH
05 1SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH Minden DE
06 1WUHAN WUYAO PHARMACEUTICAL CO., LTD. Huangshi City CN
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Certificate Number : CEP 2017-054 - Rev 01
Status : Valid
Issue Date : 2024-03-25
Type : Chemical
Substance Number : 1162
Certificate Number : R1-CEP 2011-369 - Rev 01
Status : Valid
Issue Date : 2020-03-03
Type : Chemical
Substance Number : 1162
59
PharmaCompass offers a list of Xylometazoline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Xylometazoline Hydrochloride manufacturer or Xylometazoline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Xylometazoline Hydrochloride manufacturer or Xylometazoline Hydrochloride supplier.
PharmaCompass also assists you with knowing the Xylometazoline Hydrochloride API Price utilized in the formulation of products. Xylometazoline Hydrochloride API Price is not always fixed or binding as the Xylometazoline Hydrochloride Price is obtained through a variety of data sources. The Xylometazoline Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Novartis brand of xylometazoline hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Novartis brand of xylometazoline hydrochloride, including repackagers and relabelers. The FDA regulates Novartis brand of xylometazoline hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Novartis brand of xylometazoline hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Novartis brand of xylometazoline hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Novartis brand of xylometazoline hydrochloride supplier is an individual or a company that provides Novartis brand of xylometazoline hydrochloride active pharmaceutical ingredient (API) or Novartis brand of xylometazoline hydrochloride finished formulations upon request. The Novartis brand of xylometazoline hydrochloride suppliers may include Novartis brand of xylometazoline hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Novartis brand of xylometazoline hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Novartis brand of xylometazoline hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Novartis brand of xylometazoline hydrochloride Certificate of Suitability (COS). The purpose of a Novartis brand of xylometazoline hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Novartis brand of xylometazoline hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Novartis brand of xylometazoline hydrochloride to their clients by showing that a Novartis brand of xylometazoline hydrochloride CEP has been issued for it. The manufacturer submits a Novartis brand of xylometazoline hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Novartis brand of xylometazoline hydrochloride CEP holder for the record. Additionally, the data presented in the Novartis brand of xylometazoline hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Novartis brand of xylometazoline hydrochloride DMF.
A Novartis brand of xylometazoline hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Novartis brand of xylometazoline hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Novartis brand of xylometazoline hydrochloride suppliers with CEP (COS) on PharmaCompass.
We have 5 companies offering Novartis brand of xylometazoline hydrochloride
Get in contact with the supplier of your choice:
